146 related articles for article (PubMed ID: 34580803)
1. Endogenous testosterone density predicts unfavorable disease at final pathology in intermediate risk prostate cancer.
Porcaro AB; Tafuri A; Panunzio A; Rizzetto R; Amigoni N; Cerrato C; Shakir A; Gallina S; Bianchi A; Cianflone F; Serafin E; Gozzo A; Di Filippo G; Migliorini F; Novella G; Brunelli M; Cerruto MA; Antonelli A
Int Urol Nephrol; 2021 Dec; 53(12):2517-2526. PubMed ID: 34580803
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection.
Porcaro AB; Panunzio A; Tafuri A; Cerrato C; Gallina S; Bianchi A; Rizzetto R; Amigoni N; Gozzo A; Serafin E; Cianflone F; Migliorini F; Vidiri S; Di Filippo G; Novella G; Brunelli M; Shakir A; Pagliarulo V; Cerruto MA; Siracusano S; Antonelli A
Urol Int; 2022; 106(9):928-939. PubMed ID: 35081537
[TBL] [Abstract][Full Text] [Related]
3. Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancer.
Porcaro AB; Gallina S; Bianchi A; Cerrato C; Tafuri A; Rizzetto R; Amigoni N; Orlando R; Serafin E; Gozzo A; Migliorini F; Antoniolli SZ; Lacola V; De Marco V; Brunelli M; Cerruto MA; Siracusano S; Antonelli A
Int Urol Nephrol; 2021 Dec; 53(12):2505-2515. PubMed ID: 34677784
[TBL] [Abstract][Full Text] [Related]
4. Positive independent association between preoperative endogenous testosterone density and tumor load density in surgical specimen of patients undergoing radical prostatectomy.
Porcaro AB; Bianchi A; Gallina S; Serafin E; Mazzucato G; Panunzio A; Tafuri A; Montanaro F; Marafioti Patuzzo G; Baielli A; Artoni F; Vidiri S; Cianflone F; D'Aietti D; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
Urologia; 2024 Feb; 91(1):76-84. PubMed ID: 37526101
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of endogenous testosterone density on prostate cancer progression in patients with very favorable low and intermediate risk treated with radical prostatectomy.
Porcaro AB; Tafuri A; Panunzio A; Cerrato C; Bianchi A; Gallina S; Vidiri S; D'Aietti D; Serafin E; Mazzucato G; Princiotta A; Brusa D; Brunelli M; Pagliarulo V; Cerruto MA; Antonelli A
Asian J Androl; 2023 Jan; 25(5):556-63. PubMed ID: 36629157
[TBL] [Abstract][Full Text] [Related]
6. Endogenous testosterone density is an independent predictor of pelvic lymph node invasion in high-risk prostate cancer: results in 201 consecutive patients treated with radical prostatectomy and extended pelvic lymph node dissection.
Porcaro AB; Tafuri A; Panunzio A; Mazzucato G; Cerrato C; Gallina S; Bianchi A; Rizzetto R; Amigoni N; Serafin E; Cianflone F; Orlando R; Gentile I; Migliorini F; Zecchini Antoniolli S; Di Filippo G; Brunelli M; Pagliarulo V; Cerruto MA; Antonelli A
Int Urol Nephrol; 2022 Mar; 54(3):541-550. PubMed ID: 35044553
[TBL] [Abstract][Full Text] [Related]
7. Total testosterone density predicts high tumor load and disease reclassification of prostate cancer: results in 144 low-risk patients who underwent radical prostatectomy.
Porcaro AB; Tafuri A; Sebben M; Processali T; Pirozzi M; Shakir A; Amigoni N; Rizzetto R; Brunelli M; Migliorini F; Siracusano S; Artibani W
Int Urol Nephrol; 2019 Dec; 51(12):2169-2180. PubMed ID: 31444696
[TBL] [Abstract][Full Text] [Related]
8. Preoperative endogenous testosterone density predicts disease progression from localized impalpable prostate cancer presenting with PSA levels elevated up to 10 ng/mL.
Porcaro AB; Bianchi A; Mazzucato G; Gallina S; Serafin E; Tafuri A; Cerrato C; Panunzio A; Vidiri S; D'Aietti D; Orlando R; Brusa D; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
Int Urol Nephrol; 2023 Jan; 55(1):85-92. PubMed ID: 36197572
[TBL] [Abstract][Full Text] [Related]
9. Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer.
Porcaro AB; De Luyk N; Corsi P; Sebben M; Tafuri A; Processali T; Cerasuolo M; Mattevi D; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Urol Int; 2017; 99(2):215-221. PubMed ID: 28245478
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
[TBL] [Abstract][Full Text] [Related]
11. Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies.
Ferro M; Lucarelli G; de Cobelli O; Vartolomei MD; Damiano R; Cantiello F; Crocerossa F; Perdonà S; Del Prete P; Cordima G; Musi G; Del Giudice F; Busetto GM; Chung BI; Porreca A; Ditonno P; Battaglia M; Terracciano D
World J Urol; 2021 Jun; 39(6):1861-1867. PubMed ID: 32683462
[TBL] [Abstract][Full Text] [Related]
12. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
13. Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy.
Gao Y; Jiang CY; Mao SK; Cui D; Hao KY; Zhao W; Jiang Q; Ruan Y; Xia SJ; Han BM
Asian J Androl; 2016; 18(4):639-43. PubMed ID: 26732103
[TBL] [Abstract][Full Text] [Related]
14. Tumor upgrading among very favorable intermediate-risk prostate cancer patients treated with robot-assisted radical prostatectomy: how can it impact the clinical course?
Porcaro AB; Bianchi A; Panunzio A; Gallina S; Serafin E; Tafuri A; Trabacchin N; Orlando R; Ornaghi PI; Mazzucato G; Vidiri S; D'Aietti D; Montanaro F; Brusa D; Patuzzo GM; Artoni F; Baielli A; Migliorini F; De Marco V; Veccia A; Brunelli M; Siracusano S; Cerruto MA; Antonelli A
Int Urol Nephrol; 2024 Mar; ():. PubMed ID: 38553619
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
Faisal FA; Sundi D; Pierorazio PM; Ball MW; Humphreys EB; Han M; Epstein JI; Partin AW; Carter HB; Bivalacqua TJ; Schaeffer EM; Ross AE
BJU Int; 2014 Dec; 114(6b):E120-E129. PubMed ID: 24731026
[TBL] [Abstract][Full Text] [Related]
16. Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.
Ferro M; Lucarelli G; Bruzzese D; Di Lorenzo G; Perdonà S; Autorino R; Cantiello F; La Rocca R; Busetto GM; Cimmino A; Buonerba C; Battaglia M; Damiano R; De Cobelli O; Mirone V; Terracciano D
Oncotarget; 2017 Mar; 8(11):18424-18434. PubMed ID: 27793023
[TBL] [Abstract][Full Text] [Related]
17. The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.
Porcaro AB; Caruso B; Terrin A; De Luyk N; Cacciamani G; Corsi P; Inverardi D; De Marchi D; Baldassarre R; Cerruto M; Ghimenton C; Brunelli M; Zecchini Antoniolli S; Petrozziello A; Artibani W
Arch Ital Urol Androl; 2016 Mar; 88(1):17-22. PubMed ID: 27072171
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy.
Takeshima Y; Yamada Y; Teshima T; Fujimura T; Kakutani S; Hakozaki Y; Kimura N; Akiyama Y; Sato Y; Kawai T; Yamada D; Kume H
BMC Cancer; 2021 May; 21(1):501. PubMed ID: 33947348
[TBL] [Abstract][Full Text] [Related]
19. Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease.
Porcaro AB; Panunzio A; Serafin E; Bianchi A; Gallina S; Mazzucato G; Vidiri S; D'Aietti D; Orlando R; Ditonno F; Montanaro F; Marafioti Patuzzo G; Bailelli A; Artoni F; Zecchini Antoniolli S; Rizzetto R; Brunelli M; Siracusano S; Cerruto MA; Tafuri A; Antonelli A
Int Urol Nephrol; 2023 May; 55(5):1139-1148. PubMed ID: 36943597
[TBL] [Abstract][Full Text] [Related]
20. Determination of Whether Apex or Non-Apex Prostate Cancer Is the Best Candidate for the Use of Prostate-Specific Antigen Density to Predict Pathological Grade Group Upgrading and Upstaging after Radical Prostatectomy.
Huang C; He S; He Q; Gong Y; Song G; Zhou L
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
